Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12746710 [patent_doc_number] => 20180140737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => HAEMOSTATIC MATERIAL [patent_app_type] => utility [patent_app_number] => 15/572908 [patent_app_country] => US [patent_app_date] => 2016-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -59 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15572908 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/572908
HAEMOSTATIC MATERIAL May 10, 2016 Abandoned
Array ( [id] => 17280901 [patent_doc_number] => 11197914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-14 [patent_title] => GLP-1R/GCGR dual target agonist polypeptide for treatment of fatty liver diseases, hyperlipemia and arteriosclerosis [patent_app_type] => utility [patent_app_number] => 16/089228 [patent_app_country] => US [patent_app_date] => 2016-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 6960 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089228 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/089228
GLP-1R/GCGR dual target agonist polypeptide for treatment of fatty liver diseases, hyperlipemia and arteriosclerosis May 10, 2016 Issued
Array ( [id] => 11040162 [patent_doc_number] => 20160237118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'LEUKEMIA STEM CELL TARGETING LIGANDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/142912 [patent_app_country] => US [patent_app_date] => 2016-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21592 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142912 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/142912
Leukemia stem cell targeting ligands and methods of use Apr 28, 2016 Issued
Array ( [id] => 14820963 [patent_doc_number] => 10407473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Methods for treating disorders that involve immunoglobulin A [patent_app_type] => utility [patent_app_number] => 15/139710 [patent_app_country] => US [patent_app_date] => 2016-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13873 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15139710 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/139710
Methods for treating disorders that involve immunoglobulin A Apr 26, 2016 Issued
Array ( [id] => 11034384 [patent_doc_number] => 20160231340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/137705 [patent_app_country] => US [patent_app_date] => 2016-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10223 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137705 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/137705
Ultra-small apoB-containing particles and methods of use thereof Apr 24, 2016 Issued
Array ( [id] => 14088079 [patent_doc_number] => 10239933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-26 [patent_title] => Compositions and methods for modulating thrombin generation [patent_app_type] => utility [patent_app_number] => 15/131385 [patent_app_country] => US [patent_app_date] => 2016-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 28 [patent_no_of_words] => 10777 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131385 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/131385
Compositions and methods for modulating thrombin generation Apr 17, 2016 Issued
Array ( [id] => 11025104 [patent_doc_number] => 20160222058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/131662 [patent_app_country] => US [patent_app_date] => 2016-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10545 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131662 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/131662
BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME Apr 17, 2016 Abandoned
Array ( [id] => 12702274 [patent_doc_number] => 20180125924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => SUPRAMOLECULAR GLYCOSAMINOGLYCANS [patent_app_type] => utility [patent_app_number] => 15/566066 [patent_app_country] => US [patent_app_date] => 2016-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20110 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566066 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/566066
Supramolecular gylcosaminoglycans Apr 12, 2016 Issued
Array ( [id] => 14454253 [patent_doc_number] => 10323078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases [patent_app_type] => utility [patent_app_number] => 15/559984 [patent_app_country] => US [patent_app_date] => 2016-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 32 [patent_no_of_words] => 18340 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559984 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/559984
Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases Mar 20, 2016 Issued
Array ( [id] => 15309659 [patent_doc_number] => 10519521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Method of preventing carbohydrate crystallization [patent_app_type] => utility [patent_app_number] => 15/067012 [patent_app_country] => US [patent_app_date] => 2016-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 22 [patent_no_of_words] => 6516 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15067012 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/067012
Method of preventing carbohydrate crystallization Mar 9, 2016 Issued
Array ( [id] => 11129241 [patent_doc_number] => 20160326217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'Methods and Compositions Related to Cyclic Peptide Synthesis' [patent_app_type] => utility [patent_app_number] => 15/061723 [patent_app_country] => US [patent_app_date] => 2016-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 38516 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061723 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/061723
Methods and Compositions Related to Cyclic Peptide Synthesis Mar 3, 2016 Abandoned
Array ( [id] => 10820418 [patent_doc_number] => 20160166582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'PROTEASOME INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/050502 [patent_app_country] => US [patent_app_date] => 2016-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15815 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050502 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/050502
PROTEASOME INHIBITORS AND USES THEREOF Feb 22, 2016 Abandoned
Array ( [id] => 10978457 [patent_doc_number] => 20160175399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'IL-13 RECEPTOR BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 15/045557 [patent_app_country] => US [patent_app_date] => 2016-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9481 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045557 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/045557
IL-13 receptor binding peptides Feb 16, 2016 Issued
Array ( [id] => 15663781 [patent_doc_number] => 10596095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-24 [patent_title] => Method for moisturizing skin using P-113 peptide [patent_app_type] => utility [patent_app_number] => 15/550030 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3993 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550030 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/550030
Method for moisturizing skin using P-113 peptide Feb 3, 2016 Issued
Array ( [id] => 12138230 [patent_doc_number] => 20180016313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'MODIFIED DKK2 PROTEIN, NUCLEIC ACID ENCODING THE SAME, PREPARATION METHOD THEREOF, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/548580 [patent_app_country] => US [patent_app_date] => 2016-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7774 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548580 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/548580
Modified DKK2 protein, nucleic acid encoding the same, preparation method thereof, and use thereof Feb 2, 2016 Issued
Array ( [id] => 15604355 [patent_doc_number] => 10583218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Composite containing collagen and elastin as a dermal expander and tissue filler [patent_app_type] => utility [patent_app_number] => 15/012257 [patent_app_country] => US [patent_app_date] => 2016-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 12318 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012257 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/012257
Composite containing collagen and elastin as a dermal expander and tissue filler Jan 31, 2016 Issued
Array ( [id] => 16696701 [patent_doc_number] => 10947282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Functionalized protein-based materials and their uses [patent_app_type] => utility [patent_app_number] => 15/544216 [patent_app_country] => US [patent_app_date] => 2016-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3003 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544216 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/544216
Functionalized protein-based materials and their uses Jan 19, 2016 Issued
Array ( [id] => 11009750 [patent_doc_number] => 20160206703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/996800 [patent_app_country] => US [patent_app_date] => 2016-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8793 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996800 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/996800
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS Jan 14, 2016 Abandoned
Array ( [id] => 11011284 [patent_doc_number] => 20160208237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY' [patent_app_type] => utility [patent_app_number] => 14/991823 [patent_app_country] => US [patent_app_date] => 2016-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7995 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991823 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/991823
Modifications of peptide compositions to increase stability and delivery efficiency Jan 7, 2016 Issued
Array ( [id] => 13714281 [patent_doc_number] => 20170368095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => MAGNESIUM-CONTAINING OXYTOCIN FORMULATIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/541991 [patent_app_country] => US [patent_app_date] => 2016-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25832 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541991 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/541991
Magnesium-containing oxytocin formulations and methods of use Jan 6, 2016 Issued
Menu